Skip to main content

Saniona

Saniona AB is a Swedish clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines targeting ion channels for neurological and psychiatric diseases. The company utilizes its proprietary ion channel drug discovery platform to develop treatments for rare neurological disorders, epilepsy, and psychiatric conditions. Its clinical development pipeline encompasses preclinical research, drug candidate synthesis, and clinical trial management. As a biopharmaceutical research firm, the company generates minimal commercial revenue and finances its operations through capital market offerings, research grants, and pharmaceutical partnerships. Saniona holds a specialized position in ion channel pharmacology and neuroscience drug discovery. The company is headquartered in Copenhagen, Denmark, with research operations in Sweden, and its shares trade on Nasdaq Stockholm.

3 of the funds FundTelligence covers report a position in Saniona.

Legal name
Saniona AB
Sector
Health Care
Country
Sweden
Funds holding it
3

Funds holding Saniona

Loading...